SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: mplaut who wrote (12232)7/15/2013 12:51:09 PM
From: Mimbari2 Recommendations

Recommended By
Jack Russell
mplaut

  Read Replies (1) | Respond to of 13111
 
For the record, pv-10 is the only cytotoxic out there that is toxic to just cancer cells. Let us be clear on that and understand how big that is. It means its the end of side effects of cancer treatments. You get to keep your hair, your energy, and the contents of your stomach.



To: mplaut who wrote (12232)7/15/2013 1:18:06 PM
From: NTTG1 Recommendation

Recommended By
Pogeu Mahone

  Respond to of 13111
 
I understood it was not your list.

several PII and small series studies have looked at Bleomycin + ECT - in general CR in 75/84 lesions, PR in 8/84....did not prevent new lesions from forming
J Am Acad Dermatol. 2011 Feb;64(2):413-22. doi: 10.1016/j.jaad.2009.12.013. Epub 2010 Mar 23.

Older literature is available on 5-FU and methotrexate, also with better CR/PR in stage III and IV patients


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News